TATVASpecialty Chemicals
Tatva Chintan Pharma Chem Limited — Cash Flow Statement
₹1052.40
-5.07%
Tatva Chintan Pharma Chem Limited Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -51.60 Cr | -30.47 Cr | -175.33 Cr | -68.93 Cr | — |
| Repayment Of Debt | -3.22 Cr | -8.66 Cr | -13.94 Cr | -13.43 Cr | — |
| Issuance Of Debt | 40000.00 | 0.00 | 0.83 Cr | 42.28 Cr | — |
| Issuance Of Capital Stock | 0.00 | 196.60 Cr | 0.00 | 211.10 Cr | — |
| Capital Expenditure | -76.27 Cr | -128.51 Cr | -203.11 Cr | -89.16 Cr | — |
| End Cash Position | 11.37 Cr | 35.30 Cr | 27.36 Cr | 63.02 Cr | — |
| Beginning Cash Position | 35.30 Cr | 27.36 Cr | 63.02 Cr | 4.48 Cr | — |
| Effect Of Exchange Rate Changes | 0.09 Cr | -0.08 Cr | -0.09 Cr | 0.02 Cr | — |
| Changes In Cash | -24.02 Cr | 8.02 Cr | -35.57 Cr | 58.55 Cr | — |
| Financing Cash Flow | 16.57 Cr | 30.52 Cr | 37.80 Cr | 235.01 Cr | — |
| Interest Paid Cff | -1.29 Cr | -6.53 Cr | -8.40 Cr | -4.95 Cr | — |
| Cash Dividends Paid | -4.68 Cr | -4.68 Cr | -4.43 Cr | — | -4.02 Cr |
| Net Common Stock Issuance | 0.00 | 196.60 Cr | 0.00 | 211.10 Cr | — |
| Common Stock Issuance | 0.00 | 196.60 Cr | 0.00 | 211.10 Cr | — |
| Net Issuance Payments Of Debt | 22.53 Cr | -154.87 Cr | 50.63 Cr | 28.86 Cr | — |
| Net Short Term Debt Issuance | 25.75 Cr | -146.21 Cr | 63.74 Cr | 42.28 Cr | — |
| Net Long Term Debt Issuance | -3.21 Cr | -8.66 Cr | -13.11 Cr | -13.43 Cr | — |
| Long Term Debt Payments | -3.22 Cr | -8.66 Cr | -13.94 Cr | -13.43 Cr | — |
| Long Term Debt Issuance | 40000.00 | 0.00 | 0.83 Cr | 0.00 | — |
| Investing Cash Flow | -65.25 Cr | -120.54 Cr | -101.14 Cr | -196.69 Cr | — |
| Interest Received Cfi | 0.49 Cr | 3.27 Cr | 5.33 Cr | 4.66 Cr | — |
| Net Investment Purchase And Sale | 10.39 Cr | 4.55 Cr | 96.57 Cr | -112.27 Cr | — |
| Sale Of Investment | 10.39 Cr | 25.27 Cr | 96.57 Cr | — | 0.25 Cr |
| Purchase Of Investment | 0.00 | -20.72 Cr | 0.00 | — | — |
| Net PPE Purchase And Sale | -76.13 Cr | -128.36 Cr | -203.04 Cr | -89.08 Cr | — |
| Sale Of PPE | 0.14 Cr | 0.15 Cr | 0.07 Cr | 0.08 Cr | — |
| Purchase Of PPE | -76.27 Cr | -128.51 Cr | -203.11 Cr | -89.16 Cr | — |
| Operating Cash Flow | 24.67 Cr | 98.04 Cr | 27.78 Cr | 20.23 Cr | — |
| Taxes Refund Paid | -4.50 Cr | -8.56 Cr | -9.29 Cr | -18.41 Cr | — |
| Change In Working Capital | -7.72 Cr | 34.44 Cr | -24.40 Cr | -77.11 Cr | — |
| Change In Other Current Liabilities | 8.15 Cr | 0.95 Cr | -8.36 Cr | 10.62 Cr | — |
| Change In Other Current Assets | -6.54 Cr | -3.10 Cr | 16.31 Cr | -19.20 Cr | — |
| Change In Payable | -13.11 Cr | 11.25 Cr | -12.37 Cr | -3.06 Cr | — |
| Change In Inventory | 18.81 Cr | 9.73 Cr | 7.46 Cr | -97.94 Cr | — |
| Change In Receivables | -15.16 Cr | 15.38 Cr | -28.07 Cr | 32.30 Cr | — |
| Other Non Cash Items | 1.75 Cr | 3.56 Cr | 7.55 Cr | 0.31 Cr | — |
| Depreciation And Amortization | 27.66 Cr | 25.61 Cr | 9.55 Cr | 8.18 Cr | — |
| Depreciation | 27.66 Cr | 25.61 Cr | 9.40 Cr | 8.13 Cr | — |
| Gain Loss On Investment Securities | -0.07 Cr | -0.19 Cr | — | — | 0.03 Cr |
| Net Foreign Currency Exchange Gain Loss | -0.02 Cr | -0.38 Cr | -0.41 Cr | 3.14 Cr | — |
| Net Income From Continuing Operations | 7.58 Cr | 43.57 Cr | 44.78 Cr | 104.12 Cr | — |
| Net Other Financing Charges | — | 195.37 Cr | — | -0.95 Cr | 3.98 Cr |
| Amortization Cash Flow | — | 0.21 Cr | 0.15 Cr | 0.05 Cr | 0.06 Cr |
| Other Cash Adjustment Outside Changein Cash | — | — | -10000.00 | -0.04 Cr | — |
| Short Term Debt Issuance | — | — | 63.74 Cr | 42.28 Cr | 8.80 Cr |
| Provisionand Write Offof Assets | — | — | — | -0.29 Cr | 0.16 Cr |
| Gain Loss On Sale Of PPE | — | — | — | 0.05 Cr | 0.03 Cr |
| Net Other Investing Changes | — | — | — | — | 0.07 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Tatva Chintan Pharma Chem Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.